Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements

Immunogenetics. 1994;40(1):54-61. doi: 10.1007/BF00163964.

Abstract

In melanoma, HLA class I expression is suppressed by overexpression of the c-myc oncogene. This suppression has severe consequences for the recognition of these tumor cells by the immune system of the organism. We show here that transcription of the HLA-B locus, which is mainly affected by c-Myc, is downmodulated at the level of initiation of transcription. The transcriptional activity of various HLA-B reporter constructs was tested in a melanoma cell line with low endogenous c-myc expression and in transfectants with high stable and transient c-myc expression. We demonstrated that the responsive region can be mapped to the core promoter region of HLA class I, ruling out any effects of c-myc overexpression on the enhancer A or enhancer B regions. The region subject to downregulation is confined to a 43 base pair fragment encompassing the CCAAT and TATA elements. By coupling this region to a heterologous viral enhancer, we showed that the downmodulation by c-Myc is independent of the presence and nature of an enhancer. These results suggest a mechanism in which c-Myc downregulates the expression of HLA class I genes by interfering with the basal level of transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • DNA Mutational Analysis
  • Down-Regulation
  • Enhancer Elements, Genetic / genetics
  • Gene Expression Regulation, Neoplastic*
  • HLA-B Antigens / biosynthesis
  • HLA-B Antigens / genetics*
  • Humans
  • Melanoma / genetics*
  • Molecular Sequence Data
  • Promoter Regions, Genetic / genetics
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism*
  • Regulatory Sequences, Nucleic Acid / genetics*
  • Sequence Homology, Nucleic Acid
  • Suppression, Genetic
  • Transcription, Genetic
  • Transfection
  • Tumor Cells, Cultured

Substances

  • HLA-B Antigens
  • Proto-Oncogene Proteins c-myc